Abeona Therapeutics Inc.
ABEO· Nasdaq
Released Nov 16, 2015, after the close
10-Q filed Nov 16, 2015, 47 days after period end · 0001144204-15-066026
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2015 | Q3 2014 | Q3 2013 | Q3 2012 |
|---|---|---|---|---|
| Revenue | $285.00K | $236.00K | $189.00K | $871.00K |
| Net Income | -$6.07M | -$1.47M | -$157.00K | -$14.87M |
| EPS Diluted | -$0.19 |
Abeona Therapeutics Inc. · CIK 318306 · Engraved from SEC EDGAR
| -$4.15 |
| -$1.77 |
| -$0.63 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.